{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:06:41Z","timestamp":1794280001372,"version":"4.9.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["161L0222"],"award-info":[{"award-number":["161L0222"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"EC | ERC | HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101115681"],"award-info":[{"award-number":["101115681"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["Young Investigator Grant 2022"],"award-info":[{"award-number":["Young Investigator Grant 2022"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Berliner Krebsgesellschaft Grant","award":["DRFF202204"],"award-info":[{"award-number":["DRFF202204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Syst Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-grade serous ovarian cancer (HGSOC) is often detected at an advanced stage, where curative treatment options are limited. Recent advances in ultrasensitive mass spectrometry-based spatial proteomics have provided a unique opportunity to uncover molecular drivers of early tumorigenesis and novel therapeutic targets. Here, we present a comprehensive proteomic analysis of serous tubal intraepithelial carcinoma (STIC), the HGSOC precursor lesion, and concurrent invasive carcinoma, covering more than 10,000 proteins from ultra-low input archival tissue. STIC and HGSOC showed highly similar proteomes, clustering into two subtypes with distinct tumor-immune microenvironments and common remodeling of the extracellular matrix. We discovered cell-of-origin signatures from secretory fallopian tube epithelial cells in STICs and identified early dysregulated pathways of therapeutic relevance. Targeting cholesterol biosynthesis by inhibiting the terminal steps via DHCR7 showed therapeutic effects in ovarian cancer cell lines and synergized with standard-of-care carboplatin treatment. This study demonstrates the power of spatially resolved quantitative proteomics in understanding early carcinogenesis and provides a rich resource for biomarker and drug target research.<\/jats:p>","DOI":"10.1038\/s44320-025-00168-4","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:40:42Z","timestamp":1763026842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets"],"prefix":"10.1038","volume":"22","author":[{"given":"Anuar","family":"Makhmut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea P","family":"Dragomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-3534","authenticated-orcid":false,"given":"Sonja","family":"Fritzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-3032","authenticated-orcid":false,"given":"Markus","family":"Moebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7870-138X","authenticated-orcid":false,"given":"Wolfgang D","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-694X","authenticated-orcid":false,"given":"Eliane T","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-5081","authenticated-orcid":false,"given":"Fabian","family":"Coscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"168_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M (2016) Mass-spectrometric exploration of proteome structure and function. Nature 537:347\u2013355","journal-title":"Nature"},{"key":"168_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2008.05.031","volume":"110","author":"N Auersperg","year":"2008","unstructured":"Auersperg N, Woo MMM, Gilks CB (2008) The origin of ovarian carcinomas: a developmental view. Gynecol Oncol 110:452\u2013454","journal-title":"Gynecol Oncol"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA (2021) Therapeutic targeting of the tumor microenvironment. Cancer Discov 11:933\u2013959","journal-title":"Cancer Discov"},{"key":"168_CR4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"D Bell","year":"2011","unstructured":"Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F, Dhir R, Disaia P, Gabra H, Glenn P et al (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474:609\u2013615","journal-title":"Nature"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R et al (2018) Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560:325\u2013330","journal-title":"Nature"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell DD, B\u00f6hm S, Ahmed AA, Aspuria P-J, Bast RC, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA et al (2015) Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer 15:668\u2013679","journal-title":"Nat Rev Cancer"},{"key":"168_CR7","unstructured":"Brisson BK, Dekky B, Berger AC, Mauldin EA, Loebel C, Yen W, Stewart DC, Gillette D, Assenmacher C-A, Cukierman E et al (2023) Tumor-restrictive type III collagen in the breast cancer microenvironment: prognostic and therapeutic implications. Preprint at Research Square 10.21203\/rs.3.rs-2631314\/v1"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","volume":"24","author":"GM Chen","year":"2018","unstructured":"Chen GM, Kannan L, Geistlinger L, Kofia V, Safikhani Z, Gendoo DMA, Parmigiani G, Birrer M, Haibe-Kains B, Waldron L (2018) Consensus on molecular subtypes of high-grade serous ovarian carcinoma. Clin Cancer Res 24:5037\u20135047","journal-title":"Clin Cancer Res"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","volume":"20","author":"DJ Cheon","year":"2014","unstructured":"Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE et al (2014) A collagen-remodeling gene signature regulated by TGF-\u03b2 signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res 20:711\u2013723","journal-title":"Clin Cancer Res"},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","volume":"186","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury S, Kennedy JJ, Ivey RG, Murillo OD, Hosseini N, Song X, Petralia F, Calinawan A, Savage SR, Berry AB et al (2023) Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer. Cell 186:3476\u20133498.e35","journal-title":"Cell"},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","volume":"175","author":"F Coscia","year":"2018","unstructured":"Coscia F, Lengyel E, Duraiswamy J, Mund A, Mann M, Curtis M, Coscia F, Lengyel E, Duraiswamy J, Ashcroft B et al (2018) Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer article multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer. Cell 175:159\u2013170","journal-title":"Cell"},{"key":"168_CR12","volume":"13","author":"J Cox","year":"2012","unstructured":"Cox J, Mann M (2012) 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 13:S12","journal-title":"BMC Bioinformatics"},{"key":"168_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","volume":"5","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5:35\u201344","journal-title":"Clin Med Res"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"101055","DOI":"10.1016\/j.xcrm.2023.101055","volume":"4","author":"P Cunnea","year":"2023","unstructured":"Cunnea P, Curry EW, Christie EL, Nixon K, Kwok CH, Pandey A, Wulandari R, Thol K, Ploski J, Morera-Albert C et al (2023) Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes. Cell Rep Med 4:101055","journal-title":"Cell Rep Med"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M (2020) DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods 17:41\u201344","journal-title":"Nat Methods"},{"key":"168_CR16","doi-asserted-by":"crossref","unstructured":"Denisenko E, Kock L De, Tan A, Beasley AB, Beilin M, Jones ME, Hou R, Muir\u00ed D\u00d3, Bilic S, Mohan GRKA et al (2024) Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones. Nat Commun 15:2860","DOI":"10.1038\/s41467-024-47271-y"},{"key":"168_CR17","doi-asserted-by":"crossref","first-page":"108978","DOI":"10.1016\/j.celrep.2021.108978","volume":"35","author":"HQ Dinh","year":"2021","unstructured":"Dinh HQ, Lin X, Abbasi F, Nameki R, Haro M, Olingy CE, Chang H, Hernandez L, Gayther SA, Wright KN et al (2021) Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube. Cell Rep 35:108978","journal-title":"Cell Rep"},{"key":"168_CR18","first-page":"1","volume":"15","author":"J Dufresne","year":"2018","unstructured":"Dufresne J, Bowden P, Thavarajah T, Florentinus-Mefailoski A, Chen ZZ, Tucholska M, Norzin T, Ho MT, Phan M, Mohamed N et al (2018) The plasma peptides of ovarian cancer. Clin Proteom 15:1\u201319","journal-title":"Clin Proteom"},{"key":"168_CR19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, Tienda SM, Nahotko DA, Li G, Bla\u017eenovi\u0107 I et al (2019) Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569:723\u2013728","journal-title":"Nature"},{"key":"168_CR20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","volume":"6","author":"MA Eckert","year":"2016","unstructured":"Eckert MA, Pan S, Hernandez KM, Loth RM, Andrade J, Volchenboum SL, Faber P, Montag A, Lastra R, Peter ME et al (2016) Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube. Cancer Discov 6:1342\u20131351","journal-title":"Cancer Discov"},{"key":"168_CR21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","volume":"109","author":"AK Folkins","year":"2008","unstructured":"Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP (2008) A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 109:168\u2013173","journal-title":"Gynecol Oncol"},{"key":"168_CR22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acs.jproteome.2c00145","volume":"21","author":"AM Frankenfield","year":"2022","unstructured":"Frankenfield AM, Ni J, Ahmed M, Hao L (2022) Protein contaminants matter: building universal protein contaminant libraries for DDA and DIA proteomics. J Proteome Res 21:2104\u20132113","journal-title":"J Proteome Res"},{"key":"168_CR23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cell.2011.12.017","volume":"148","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor WA, Mizuno H, Zhao X, Langer\u00f8d A, Moon SH, Rodriguez-Barrueco R, Barsotti A, Chicas A, Li W, Polotskaia A et al (2012) Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 148:244\u2013258","journal-title":"Cell"},{"key":"168_CR24","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1","DOI":"10.1126\/scisignal.2004088"},{"key":"168_CR25","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","volume":"80","author":"L Geistlinger","year":"2021","unstructured":"Geistlinger L, Oh S, Ramos M, Schiffer L, LaRue RS, Henzler CM, Munro SA, Daughters C, Nelson AC, Winterhoff BJ et al (2021) Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma. Cancer Res 80:4335\u20134345","journal-title":"Cancer Res"},{"key":"168_CR26","doi-asserted-by":"crossref","unstructured":"Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L, Laniti DD, Coukos G (2024) Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nat Rev Clin Oncol 21:801\u2013817","DOI":"10.1038\/s41571-024-00937-4"},{"key":"168_CR27","doi-asserted-by":"crossref","unstructured":"Goss Tusher V, Tibshirani R, Chu G Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116\u20135121","DOI":"10.1073\/pnas.091062498"},{"key":"168_CR28","doi-asserted-by":"crossref","first-page":"1012002","DOI":"10.3389\/fimmu.2022.1012002","volume":"13","author":"J Gudgeon","year":"2022","unstructured":"Gudgeon J, Mar\u00edn-Rubio JL, Trost M (2022) The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer. Front Immunol 13:1012002","journal-title":"Front Immunol"},{"key":"168_CR29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"168_CR30","doi-asserted-by":"crossref","unstructured":"He J, Siu MKY, Ngan HYS, Chan KKL (2021) Aberrant cholesterol metabolism in ovarian cancer: identification of novel therapeutic targets. Front Oncol 11:738177","DOI":"10.3389\/fonc.2021.738177"},{"key":"168_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00088-6","volume":"2","author":"JP Hinestrosa","year":"2022","unstructured":"Hinestrosa JP, Kurzrock R, Lewis JM, Schork NJ, Schroeder G, Kamat AM, Lowy AM, Eskander RN, Perrera O, Searson D et al (2022) Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. Commun Med 2:1\u20139","journal-title":"Commun Med"},{"key":"168_CR32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccell.2020.01.003","volume":"37","author":"Z Hu","year":"2020","unstructured":"Hu Z, Artibani M, Alsaadi A, Wietek N, Morotti M, Shi T, Zhong Z, Santana Gonzalez L, El-Sahhar S, Carrami EM et al (2020) The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell 37:226\u2013242.e7","journal-title":"Cancer Cell"},{"key":"168_CR33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P et al (2020) A single-cell landscape of high-grade serous ovarian cancer. Nat Med 26:1271\u20131279","journal-title":"Nat Med"},{"key":"168_CR34","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1158\/1078-0432.CCR-20-1762","volume":"26","author":"KR Jordan","year":"2020","unstructured":"Jordan KR, Sikora MJ, Slansky JE, Minic A, Richer JK, Moroney MR, Hu J, Wolsky RJ, Watson ZL, Yamamoto TM et al (2020) The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval. Clin Cancer Res 26:6362\u20136373","journal-title":"Clin Cancer Res"},{"key":"168_CR35","doi-asserted-by":"crossref","unstructured":"Kader T, Lin J-R, Hug CB, Coy S, Chen Y-A, de Bruijn I, Shih N, Jung E, Pelletier RJ, Lopez Leon M et al (2024) Multimodal spatial profiling reveals immune suppression and microenvironment remodeling in fallopian tube precursors to high-grade serous ovarian carcinoma. Cancer Discov 6:1181\u20131202","DOI":"10.1158\/2159-8290.CD-24-1366"},{"key":"168_CR36","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim J, Coffey DM, Creighton CJ, Yu Z, Hawkins SM, Matzuk MM (2012) High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 109:3921\u20133926","journal-title":"Proc Natl Acad Sci USA"},{"key":"168_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C et al (2007) Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 31:161\u2013169","journal-title":"Am J Surg Pathol"},{"key":"168_CR38","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-14-3368","volume":"21","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi Y, Kashima H, Wu R-C, Jung J-G, Kuan J-C, Gu J, Xuan J, Sokoll L, Visvanathan K, Shih I-M et al (2015) Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models. Clin Cancer Res 21:4652\u20134662","journal-title":"Clin Cancer Res"},{"key":"168_CR39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","volume":"226","author":"E Kuhn","year":"2012","unstructured":"Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih IM (2012) TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol 226:421\u2013426","journal-title":"J Pathol"},{"key":"168_CR40","doi-asserted-by":"crossref","unstructured":"Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J et al (2017) High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun 8:1093","DOI":"10.1038\/s41467-017-00962-1"},{"key":"168_CR41","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1158\/0008-5472.CAN-21-0536","volume":"81","author":"LSM Lecker","year":"2021","unstructured":"Lecker LSM, Berlato C, Maniati E, Delaine-Smith R, Pearce OMT, Heath O, Nichols SJ, Trevisan C, Novak M, McDermott J et al (2021) TGFBI production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer. Cancer Res 81:5706\u20135719","journal-title":"Cancer Res"},{"key":"168_CR42","first-page":"1","volume":"10","author":"D Liu","year":"2017","unstructured":"Liu D, Mamorska-Dyga A (2017) Syk inhibitors in clinical development for hematological malignancies. J Hematol Oncol 10:1\u20137","journal-title":"J Hematol Oncol"},{"key":"168_CR43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cels.2023.10.003","volume":"14","author":"A Makhmut","year":"2023","unstructured":"Makhmut A, Qin D, Fritzsche S, Nimo J, K\u00f6nig J, Coscia F (2023) A framework for ultra-low-input spatial tissue proteomics. Cell Syst 14:1002\u20131014.e5","journal-title":"Cell Syst"},{"key":"168_CR44","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier F, Brunner AD, Frank M, Ha A, Bludau I, Voytik E, Kaspar-Schoenefeld S, Lubeck M, Raether O, Bache N et al (2020) diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition. Nat Methods 17:1229\u20131236","journal-title":"Nat Methods"},{"key":"168_CR45","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","volume":"30","author":"AK Mitra","year":"2011","unstructured":"Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, Lengyel E (2011) Ligand-independent activation of c-Met by fibronectin and \u03b15 \u03921-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30:1566\u20131576","journal-title":"Oncogene"},{"key":"168_CR46","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"SH Moon","year":"2018","unstructured":"Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP, Tschaharganeh DF, Kastenhuber ER, Barsotti AM, Culp-Hill R et al (2018) p53 represses the mevalonate pathway to mediate tumor suppression. Cell 176:564","journal-title":"Cell"},{"key":"168_CR47","doi-asserted-by":"crossref","unstructured":"Mund A, Coscia F, Kriston A, Hollandi R, Kov\u00e1cs F, Brunner A-D, Migh E, Schweizer L, Santos A, Bzorek M et al (2022) Deep Visual Proteomics defines single-cell identity and heterogeneity. Nat Biotechnol 40:1231\u20131240.","DOI":"10.1038\/s41587-022-01302-5"},{"key":"168_CR48","doi-asserted-by":"crossref","first-page":"100528","DOI":"10.1016\/j.mcpro.2023.100528","volume":"22","author":"A Naba","year":"2023","unstructured":"Naba A (2023) Ten years of extracellular matrix proteomics: accomplishments, challenges, and future perspectives. Mol Cell Proteom 22:100528","journal-title":"Mol Cell Proteom"},{"key":"168_CR49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/imt-2017-0097","volume":"10","author":"A Newland","year":"2018","unstructured":"Newland A, Lee EJ, McDonald V, Bussel JB (2018) Fostamatinib for persistent\/chronic adult immune thrombocytopenia. Immunotherapy 10:9\u201325","journal-title":"Immunotherapy"},{"key":"168_CR50","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS et al (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498\u20131503","journal-title":"Nat Med"},{"key":"168_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-31154-6","volume":"8","author":"H Nolte","year":"2018","unstructured":"Nolte H, MacVicar TD, Tellkamp F, Kr\u00fcger M (2018) Instant clue: a software suite for interactive data visualization and analysis. Sci Rep 8:1\u20138. 2018 8:1","journal-title":"Sci Rep"},{"key":"168_CR52","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","volume":"32","author":"D Nonaka","year":"2008","unstructured":"Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32:1566\u20131571","journal-title":"Am J Surg Pathol"},{"key":"168_CR53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","volume":"139","author":"M Novak","year":"2015","unstructured":"Novak M, Lester J, Karst AM, Parkash V, Hirsch MS, Crum CP, Karlan BY, Drapkin R (2015) Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecol Oncol 139:104\u2013111","journal-title":"Gynecol Oncol"},{"key":"168_CR54","doi-asserted-by":"crossref","unstructured":"Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, Van Nieuwenhuysen E, Han S, Van den Broeck A, Coosemans A et al (2021) High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med 13:111","DOI":"10.1186\/s13073-021-00922-x"},{"key":"168_CR55","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","volume":"30","author":"DY Paik","year":"2012","unstructured":"Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S (2012) Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells 30:2487\u20132497","journal-title":"Stem Cells"},{"key":"168_CR56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets R, Wyant G, Muto K, Bijron J, Poole B, Chin K, Chen J, Ohman A, Stepule C, Kwak S et al (2013) Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24:751\u2013765","journal-title":"Cancer Cell"},{"key":"168_CR57","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M et al (2019) The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res 47:D442\u2013D450","journal-title":"Nucleic Acids Res"},{"key":"168_CR58","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243\u20131253","journal-title":"EMBO Rep"},{"key":"168_CR59","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMoa2214963","volume":"388","author":"GW Prager","year":"2023","unstructured":"Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, P\u00e1pai Z et al (2023) Trifluridine\u2013tipiracil and bevacizumab in refractory metastatic colorectal cancer. N Engl J Med 388:1657\u20131667","journal-title":"N Engl J Med"},{"key":"168_CR60","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y (2024) The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov 14:1375\u20131388","journal-title":"Cancer Discov"},{"key":"168_CR78","doi-asserted-by":"crossref","unstructured":"Qian L, Zhu J, Xue Z, Zhou Y, Xiang N, Xu H, Sun R, Gong W, Cai X, Sun L, Ge W, Liu Y, Su Y, Lin W, Zhan Y, Wang J, Song S, Yi X, Ni M, Zhu Y, Hua Y, Zheng Z, Guo T (2024) Proteomic landscape of epithelial ovarian cancer. Nat Commun 15:6462","DOI":"10.1038\/s41467-024-50786-z"},{"key":"168_CR61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1369\/00221554211061359","volume":"70","author":"C Renner","year":"2022","unstructured":"Renner C, Gomez C, Visetsouk MR, Taha I, Khan A, McGregor SM, Weisman P, Naba A, Masters KS, Kreeger PK (2022) Multi-modal profiling of the extracellular matrix of human fallopian tubes and serous tubal intraepithelial carcinomas. J Histochem Cytochem 70:151\u2013168","journal-title":"J Histochem Cytochem"},{"key":"168_CR62","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-22-3645","volume":"83","author":"D Rohila","year":"2023","unstructured":"Rohila D, Park IH, Pham TV, Weitz J, de Mendoza TH, Madheswaran S, Ishfaq M, Beaman C, Tapia E, Sun S et al (2023) Syk inhibition reprograms tumor-associated macrophages and overcomes gemcitabine-induced immunosuppression in pancreatic ductal adenocarcinoma. Cancer Res 83:2675\u20132689","journal-title":"Cancer Res"},{"key":"168_CR63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","volume":"86","author":"E Schoutrop","year":"2022","unstructured":"Schoutrop E, Moyano-Galceran L, Lheureux S, Mattsson J, Lehti K, Dahlstrand H, Magalhaes I (2022) Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. Semin Cancer Biol 86:207\u2013223","journal-title":"Semin Cancer Biol"},{"key":"168_CR64","doi-asserted-by":"crossref","first-page":"100039","DOI":"10.1016\/j.crmeth.2021.100039","volume":"1","author":"R Sinha","year":"2021","unstructured":"Sinha R, Luna A, Schultz N, Sander C (2021) A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles. Cell Rep Methods 1:100039","journal-title":"Cell Rep Methods"},{"key":"168_CR65","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.cell.2022.11.004","volume":"185","author":"S Sinha","year":"2022","unstructured":"Sinha S, Sparks HD, Labit E, Robbins HN, Gowing K, Jaffer A, Kutluberk E, Arora R, Raredon MSB, Cao L et al (2022) Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. Cell 185:4717\u20134736.e25","journal-title":"Cell"},{"key":"168_CR66","doi-asserted-by":"crossref","first-page":"105261","DOI":"10.1016\/j.jprot.2024.105261","volume":"307","author":"R Tang","year":"2024","unstructured":"Tang R, Zhu Y, Chen L, Tong J, Ma X, Sun F, Zheng L, Yu H, Yang J (2024) Lipid metabolites abnormally expressed in pelvic fluid as potential biomarkers for ovarian cancer: a case-control study. J Proteom 307:105261","journal-title":"J Proteom"},{"key":"168_CR67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/path.6207","volume":"262","author":"J Thorlacius-Ussing","year":"2024","unstructured":"Thorlacius-Ussing J, Jensen C, Nissen NI, Cox TR, Kalluri R, Karsdal M, Willumsen N (2024) The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes. J Pathol 262:22\u201336","journal-title":"J Pathol"},{"key":"168_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-44050-5","volume":"13","author":"CV Trinidad","year":"2023","unstructured":"Trinidad CV, Pathak HB, Cheng S, Tzeng SC, Madan R, Sardiu ME, Bantis LE, Deighan C, Jewell A, Rayamajhi S et al (2023) Lineage specific extracellular vesicle-associated protein biomarkers for the early detection of high grade serous ovarian cancer. Sci Rep 13:1\u201317","journal-title":"Sci Rep"},{"key":"168_CR69","doi-asserted-by":"crossref","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731\u2013740","DOI":"10.1038\/nmeth.3901"},{"key":"168_CR70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.14722","volume":"81","author":"R Vang","year":"2022","unstructured":"Vang R, Shih IM (2022) Serous tubal intra-epithelial carcinoma: what do we really know at this point?. Histopathology 81:542\u2013555","journal-title":"Histopathology"},{"key":"168_CR71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","volume":"31","author":"R Vang","year":"2012","unstructured":"Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, Li RF, Ronnett BM, Seidman JD, Yemelyanova A et al (2012) Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 31:243\u2013253","journal-title":"Int J Gynecol Pathol"},{"key":"168_CR72","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani AC, Gonzalez-Ochoa E, Alqaisi H, Madariaga A, Bhat G, Rouzbahman M, Sneha S, Oza AM (2023) Heterogeneity and treatment landscape of ovarian carcinoma. Nat Rev Clin Oncol 20:820\u2013842","journal-title":"Nat Rev Clin Oncol"},{"key":"168_CR73","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-22-1620","volume":"82","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang P, Wang BG, Murdock T, Cope L, Hsu FC, Wang TL, Shih IM (2022) Spatial transcriptomic analysis of ovarian cancer precursors reveals reactivation of IGFBP2 during pathogenesis. Cancer Res 82:4528\u20134541","journal-title":"Cancer Res"},{"key":"168_CR74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/323473","volume":"69","author":"HR Waterham","year":"2001","unstructured":"Waterham HR, Koster J, Romeijn GJ, Hennekam RCM, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI, Wanders RJA (2001) Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685\u2013694","journal-title":"Am J Hum Genet"},{"key":"168_CR75","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/cancers15133445","volume":"15","author":"EM Willing","year":"2023","unstructured":"Willing EM, Vollbrecht C, V\u00f6ssing C, Weist P, Schallenberg S, Herbst JM, Schatz S, J\u00f3ri B, Bataillon G, Harter P et al (2023) Development of the NOGGO GIS v1 assay, a comprehensive hybrid-capture-based NGS assay for therapeutic stratification of homologous repair deficiency driven tumors and clinical validation. Cancers 15:3445","journal-title":"Cancers"},{"key":"168_CR76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11:1\u201319","journal-title":"Nat Commun"},{"key":"168_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06165-5","volume":"14","author":"M Wisztorski","year":"2023","unstructured":"Wisztorski M, Aboulouard S, Roussel L, Duhamel M, Saudemont P, Cardon T, Narducci F, Robin YM, Lemaire AS, Bertin D et al (2023) Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death Dis 14:644","journal-title":"Cell Death Dis"},{"key":"168_CR79","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, Cen Y, Fei W, Zhang B, Shen Y et al (2022) Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer. Clin Cancer Res 28:3590\u20133602","journal-title":"Clin Cancer Res"},{"key":"168_CR80","doi-asserted-by":"crossref","unstructured":"Zhang H, Liu T, Zhang Z, Chan DW, Rodland KD, Zhang H, Liu T, Zhang Z, Payne SH, Zhang B et al (2016) Integrated proteogenomic characterization of human high-grade serous ovarian cancer resource integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell 166:755\u2013765","DOI":"10.1016\/j.cell.2016.05.069"},{"key":"168_CR81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203\u2013213","journal-title":"N Engl J Med"},{"key":"168_CR82","first-page":"1","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, Lin D, Wu C (2024) Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther 9:1\u201336","journal-title":"Signal Transduct Target Ther"},{"key":"168_CR83","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng S, Wang W, Aldahdooh J, Malyutina A, Shadbahr T, Tanoli Z, Pessia A, Tang J (2022) SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteomics Bioinformatics 20:587\u2013596","journal-title":"Genomics Proteomics Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s44320-025-00178-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000}}],"container-title":["Molecular Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-025-00168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44320-025-00168-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-025-00168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:23:25Z","timestamp":1786976605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44320-025-00168-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1038\/s44320-025-00168-4","relation":{},"ISSN":["1744-4292"],"issn-type":[{"value":"1744-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s44320-025-00178-2","URL":"https:\/\/doi.org\/10.1038\/s44320-025-00178-2","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"3"}}